Yardley DA, Young RR, Adelson KB, Silber AL, et al. A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC). Clin Breast Cancer 2021 Oct 28. pii: S1526-8209(21)00302.
PMID: 34824002